Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer

Cancer Letters

Volumn 369, Issue 1, 2015, Pages 67-75

  Mishra, Sanjay ^a,b   Srivastava, Amit Kumar ^a   Suman, Shankar ^a,b   Kumar, Vijay ^c   Shukla, Yogeshwer ^a,b  

^a ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Breast cancer; Circulating miRNAs; Molecular signatures; PBMCs; QRT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 106A 5P; MICRORNA 195 5P; MICRORNA 34A 5P; MICRORNA 454 3P; MICRORNA 495; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; TRANSCRIPTOME; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY CANCER; EARLY DIAGNOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRIPLE NEGATIVE BREAST CANCER; AREA UNDER THE CURVE; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; AGED; AREA UNDER CURVE; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MICRORNAS; MIDDLE AGED; ROC CURVE; TRANSCRIPTOME;

EID: 84943450761     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.07.045     Document Type: Article

References (49)

1. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol 2006, 24:2137-2150.
2. DeSantis C., Ma J., Bryan L., Jemal A. Breast cancer statistics, 2013. CA Cancer J. Clin 2014, 64:52-62.
3. Cuk K., Zucknick M., Heil J., Madhavan D., Schott S., Turchinovich A., et al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int. J. Cancer 2013, 132:1602-1612.
4. Saslow D., Boetes C., Burke W., Harms S., Leach M.O., Lehman C.D., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J. Clin 2007, 57:75-89.
5. Kriege M., Brekelmans C.T., Boetes C., Besnard P.E., Zonderland H.M., Obdeijn I.M., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N. Engl. J. Med 2004, 351:427-437.
6. Spanu A., Sanna D., Chessa F., Manca A., Cottu P., Fancellu A., et al. The clinical impact of breast scintigraphy acquired with a breast specific gamma-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography. Int. J. Oncol 2012, 41:483-489.
7. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
8. Nikiforova M.N., Tseng G.C., Steward D., Diorio D., Nikiforov Y.E. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab 2008, 93:1600-1608.
9. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2257-2261.
10. Xing L., Todd N.W., Yu L., Fang H., Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod. Pathol 2010, 23:1157-1164.
11. Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz L.A., Sjoblom T., et al. The colorectal microRNAome. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:3687-3692.
12. Eder M., Scherr M. MicroRNA and lung cancer. N. Engl. J. Med 2005, 352:2446-2448.
13. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
14. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet 2004, 5:522-531.
15. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9667-9672.
16. Hausser J., Syed A.P., Bilen B., Zavolan M. Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res 2013, 23:604-615.
17. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1608-1613.
18. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
19. Lowery A.J., Miller N., Devaney A., McNeill R.E., Davoren P.A., Lemetre C., et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 2009, 11:R27.
20. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg 2010, 251:499-505.
21. Roth C., Rack B., Muller V., Janni W., Pantel K., Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010, 12:R90.
22. Frampton A.E., Fletcher C.E., Gall T.M., Castellano L., Bevan C.L., Stebbing J., et al. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Expert Rev. Mol. Diagn 2013, 13:425-430.
23. Wang W.S., Liu L.X., Li G.P., Chen Y., Li C.Y., Jin D.Y., et al. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev. Res. (Phila.) 2013, 6:331-338.
24. Edwards C.J., Feldman J.L., Beech J., Shields K.M., Stover J.A., Trepicchio W.L., et al. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol. Med 2007, 13:40-58.
25. Bluth M., Lin Y.Y., Zhang H., Viterbo D., Zenilman M. Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis. Arch. Surg 2008, 143:227-233. discussion 233-224.
26. Twine N.C., Stover J.A., Marshall B., Dukart G., Hidalgo M., Stadler W., et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 2003, 63:6069-6075.
27. Kambas K., Markiewski M.M., Pneumatikos I.A., Rafail S.S., Theodorou V., Konstantonis D., et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J. Immunol 2008, 180:7368-7375.
28. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10513-10518.
29. Goovaerts P. Visualizing and testing the impact of place on late-stage breast cancer incidence: a non-parametric geostatistical approach. Health Place 2010, 16:321-330.
30. Stearns V., Jacobs L.K., Fackler M., Tsangaris T.N., Rudek M.A., Higgins M., et al. Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clin. Cancer Res 2013, 19:4008-4016.
31. Zou K.H., O'Malley A.J., Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007, 115:654-657.
32. Gerlach D., Kriventseva E.V., Rahman N., Vejnar C.E., Zdobnov E.M. miROrtho: computational survey of microRNA genes. Nucleic Acids Res 2009, 37:D111-D117.
33. Vlachos I.S., Kostoulas N., Vergoulis T., Georgakilas G., Reczko M., Maragkakis M., et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 2012, 40:W498-W504.
34. Huret J.L., Ahmad M., Arsaban M., Bernheim A., Cigna J., Desangles F., et al. Atlas of genetics and cytogenetics in oncology and haematology in 2013. Nucleic Acids Res 2013, 41:D920-D924.
35. Checka C.M., Chun J.E., Schnabel F.R., Lee J., Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am. J. Roentgenol 2012, 198:W292-W295.
36. Haider B.A., Baras A.S., McCall M.N., Hertel J.A., Cornish T.C., Halushka M.K. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS ONE 2014, 9:e89565.
37. Okita K., Furuhata T., Kimura Y., Kawakami M., Yamaguchi K., Tsuruma T., et al. The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression. J. Exp. Clin. Cancer Res 2005, 24:439-446.
38. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
39. Vlaicu P., Mertins P., Mayr T., Widschwendter P., Ataseven B., Hogel B., et al. Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator. BMC Cancer 2013, 13:197.
40. Squadrito M.L., Etzrodt M., De Palma M., Pittet M.J. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol 2013, 34:350-359.
41. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
42. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:19075-19080.
43. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl Cancer Inst 2002, 94:513-521.
44. Kendziorski C., Irizarry R.A., Chen K.S., Haag J.D., Gould M.N. On the utility of pooling biological samples in microarray experiments. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4252-4257.
45. Madhavan B., Yue S., Galli U., Rana S., Gross W., Muller M., et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int. J. Cancer 2015, 136(11):2616-2627.
46. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
47. Haverty P.M., Fridlyand J., Li L., Getz G., Beroukhim R., Lohr S., et al. High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 2008, 47:530-542.
48. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9136-9141.
49. Gao Y., Niu Y., Wang X., Wei L., Zhang R., Lv S., et al. Chromosome aberrations associated with centrosome defects: a study of comparative genomic hybridization in breast cancer. Hum. Pathol 2011, 42:1693-1701.